4.6 Article

MicroRNA in the Adaptive Immune System, in Sickness and in Health

Journal

JOURNAL OF CLINICAL IMMUNOLOGY
Volume 30, Issue 3, Pages 339-346

Publisher

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10875-010-9378-5

Keywords

MicroRNA; B cells; regulatory T cells; T cells; dendritic cells; cancer

Categories

Ask authors/readers for more resources

MicroRNA are emerging as key regulators of the development and function of adaptive immunity. These 19-24 nucleotide regulatory RNA molecules have essential roles in multiple faucets of adaptive immunity, from regulating the development of the key cellular players to the activation and function in immune responses. MicroRNA are involved in T cell and B cell differentiation in the thymus and bone marrow, and subsequent peripheral homeostasis. The contribution of specific microRNA to the adaptive immune response becomes even more apparent during the effector phases: class switching and germinal centre formation in B cells, differentiation into functional lineages in T cells, and activation of antigen-presentation cells through pattern-recognition pathways. With the capacity of microRNA to alter the survival and death of T and B cells, control over microRNA expression is essential to prevent adaptive immune cells from unregulated proliferation. MicroRNA can act both as 'oncomirs' and tumour suppressors, and thus dysregulation of microRNA in lymphocytes can cause malignancies. In this review, we will describe the role of microRNA in generating a productive adaptive response, and the consequences if microRNA-mediated repression of lymphocytes is perturbed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available